Tamara Morytko - 31 Dec 2025 Form 4 Insider Report for Hillenbrand, Inc. (HI)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Jan 2026, 16:21:15 UTC
Prior SEC filing
30 Dec 2025
Next SEC filing
20 Jan 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Allison A. Westfall, Attorney-in-Fact for Tamara Morytko

Key filing fact

Tamara Morytko filed Form 4 for Hillenbrand, Inc. (HI) on 05 Jan 2026.

Key facts

  • This page summarizes Tamara Morytko's Form 4 filing for Hillenbrand, Inc. (HI).
  • 6 reported transactions and 6 derivative rows are listed below.
  • Accepted by SEC: 05 Jan 2026, 16:21.

Change

  • Previous filing in this sequence was filed on 30 Dec 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001780203 Primary reporting owner

Morytko Tamara

Relationship
Sr. VP & President, MTS
Address
ONE BATESVILLE BOULEVARD, BATESVILLE
Signature
/s/ Allison A. Westfall, Attorney-in-Fact for Tamara Morytko
Signature date
05 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
8,903
Date
31 Dec 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HI transaction Derivative

Restricted Stock Units (Deferred Stock Award 09/11/2023)

Award

Transaction value
$0
Shares
+61
Change %
+0.71%
Price
$0.000000
Shares after
8,629
Date
31 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
61
Exercise price
Footnotes
F1, F2, F3
HI transaction Derivative

Restricted Stock Units (Deferred Stock Award 12/7/2023)

Award

Transaction value
$0
Shares
+17
Change %
+0.72%
Price
$0.000000
Shares after
2,393
Date
31 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
17
Exercise price
Footnotes
F1, F2, F4
HI transaction Derivative

Restricted Stock Units (Deferred Stock Award 12/5/2024)

Award

Transaction value
$0
Shares
+53
Change %
+0.71%
Price
$0.000000
Shares after
7,524
Date
31 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
53
Exercise price
Footnotes
F1, F2, F5
HI transaction Derivative

Restricted Stock Units (Matching RSU Framework 03/31/2025)

Award

Transaction value
$0
Shares
+8
Change %
+0.65%
Price
$0.000000
Shares after
1,243
Date
31 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8
Exercise price
Footnotes
F1, F2, F6
HI transaction Derivative

Restricted Stock Units (Matching RSU Framework 10/1/2025)

Award

Transaction value
$0
Shares
+16
Change %
+0.71%
Price
$0.000000
Shares after
2,264
Date
31 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
16
Exercise price
Footnotes
F1, F2, F7
HI transaction Derivative

Restricted Stock Units (Deferred Stock Award 12/4/2025)

Award

Transaction value
$0
Shares
+241
Change %
+0.72%
Price
$0.000000
Shares after
33,888
Date
31 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
241
Exercise price
Footnotes
F1, F2, F8
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock.

Footnote F2

Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates.

Footnote F3

Restricted Stock Units scheduled to vest one-quarter on 9/11/2024, one-quarter on 9/11/2025, and one-half on 9/11/2026.

Footnote F4

Restricted Stock Units scheduled to vest one-third on 12/7/2024, one-third on 12/7/2025, and one-third on 12/7/2026.

Footnote F5

Restricted Stock Units scheduled to vest one-third on 12/5/2025, one-third on 12/5/2026, and one-third on 12/5/2027.

Footnote F6

Represents Matching RSUs granted under the Company's Executive Share Match framework that will vest on March 31, 2028, and be settled in shares of the Company's common stock or cash to the extent the vesting conditions of the framework are satisfied.

Footnote F7

Represents Matching RSUs granted under the Company's Executive Share Match framework that will vest on October 1, 2028, and be settled in shares of the Company's common stock or cash to the extent the vesting conditions of the framework are satisfied.

Footnote F8

Restricted Stock Units scheduled to vest one-third on 12/4/2026, one-third on 12/4/2027, and one-third on 12/4/2028.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .